- Chile
- /
- Basic Materials
- /
- SNSE:CEMENTOS
Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings
Cementos Bio Bio S.A. (SNSE:CEMENTOS) announced strong profits, but the stock was stagnant. We did some digging, and we found some concerning factors in the details.
Check out our latest analysis for Cementos Bio Bio
The Impact Of Unusual Items On Profit
To properly understand Cementos Bio Bio's profit results, we need to consider the CL$16b gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. Which is hardly surprising, given the name. We can see that Cementos Bio Bio's positive unusual items were quite significant relative to its profit in the year to December 2021. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Cementos Bio Bio.
Our Take On Cementos Bio Bio's Profit Performance
As previously mentioned, Cementos Bio Bio's large boost from unusual items won't be there indefinitely, so its statutory earnings are probably a poor guide to its underlying profitability. As a result, we think it may well be the case that Cementos Bio Bio's underlying earnings power is lower than its statutory profit. The silver lining is that its EPS growth over the last year has been really wonderful, even if it's not a perfect measure. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For instance, we've identified 3 warning signs for Cementos Bio Bio (1 is potentially serious) you should be familiar with.
This note has only looked at a single factor that sheds light on the nature of Cementos Bio Bio's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SNSE:CEMENTOS
Cementos Bio Bio
Engages in the production and sale of cement, lime, and concrete products in Chile and internationally.
Flawless balance sheet with solid track record.